日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Summary of Research: Elranatamab Fixed Dosing-A Safe, Effective, and Convenient Dosing Approach

研究概要：Elranatamab固定剂量——一种安全、有效且便捷的给药方案

期刊:Oncology and Therapy
影响因子:3.2
doi:10.1007/s40487-026-00415-0
Elmeliegy, Mohamed; Soltantabar, Pooneh; Hibma, Jennifer; Ashman, Olivia; Wang, Diane; Lon, Hoi-Kei
发表日期：2026
文献求助 收藏

Elranatamab: Mechanism of Action, Clinical, and Translational Science

Elranatamab：作用机制、临床和转化科学

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70554
Elmeliegy, Mohamed; Viqueira, Andrea; Vandendries, Erik; Soltantabar, Pooneh; Lon, Hoi-Kei; Poels, Kamrine; Shtylla, Blerta; Irby, Donald; Bompiani-Myers, Kristin; O'Brien, Thomas; Hibma, Jennifer
发表日期：2026
文献求助 收藏

Dose Optimization of Elranatamab to Mitigate the Risk of Cytokine Release Syndrome in Patients with Multiple Myeloma

优化Elranatamab剂量以降低多发性骨髓瘤患者发生细胞因子释放综合征的风险

期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-025-01134-8
Elmeliegy, Mohamed; Viqueira, Andrea; Vandendries, Erik; Hickman, Anne; Conte, Umberto; Irby, Donald; Hibma, Jennifer; Lon, Hoi-Kei; Piscitelli, Joseph; Soltantabar, Pooneh; Skoura, Athanasia; Jiang, Sibo; Wang, Diane
多发性骨髓瘤
细胞生物学
免疫/内分泌
骨髓瘤
发表日期：2025
文献求助 收藏

Population Exposure-Response Efficacy Analysis of Elranatamab (PF-06863135) in Patients with Multiple Myeloma

在多发性骨髓瘤患者中，Elranatamab (PF-06863135) 的人群暴露-反应疗效分析

期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-025-01168-y
Lon, Hoi-Kei; Hibma, Jennifer; Jiang, Sibo; Sullivan, Sharon; Vandendries, Erik; Skoura, Athanasia; Wang, Diane; Elmeliegy, Mohamed
多发性骨髓瘤
骨髓瘤
发表日期：2025
文献求助 收藏

Elranatamab Fixed Dosing: A Safe, Effective, and Convenient Dosing Approach

Elranatamab固定剂量：一种安全、有效且便捷的给药方案

期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-025-01170-4
Elmeliegy, Mohamed; Soltantabar, Pooneh; Hibma, Jennifer; Ashman, Olivia; Wang, Diane; Lon, Hoi-Kei
发表日期：2025
文献求助 收藏

Modeling effects of dexamethasone on disease progression of bone mineral density in collagen-induced arthritic rats.

模拟地塞米松对胶原诱导关节炎大鼠骨矿物质密度疾病进展的影响

期刊:Pharmacology Research & Perspectives
影响因子:2.3
doi:10.1002/prp2.169
Lon Hoi-Kei, DuBois Debra C, Earp Justin C, Almon Richard R, Jusko William J
炎症/感染
关节炎
Rat
炎症
发表日期：2015
文献求助 收藏

Pharmacokinetics, pharmacodynamics and toxicities of methotrexate in healthy and collagen-induced arthritic rats

甲氨蝶呤在健康大鼠和胶原蛋白诱导关节炎大鼠中的药代动力学、药效学和毒性

期刊:Biopharmaceutics & Drug Disposition
影响因子:2
doi:10.1002/bdd.1838
Liu, Dong-Yang; Lon, Hoi-Kei; Wang, Yan-Lin; DuBois, Debra C; Almon, Richard R; Jusko, William J
关节炎
毒理研究
Rat
发表日期：2013
文献求助 收藏

Pharmacokinetic/pharmacodynamic modeling in inflammation

炎症中的药代动力学/药效学建模

期刊:Critical Reviews in Biomedical Engineering
影响因子:
doi:10.1615/critrevbiomedeng.v40.i4.50
Lon, Hoi-Kei; Liu, Dongyang; Jusko, William J
炎症/感染
炎症
发表日期：2012
文献求助 收藏

Population pharmacokinetic-pharmacodynamic-disease progression model for effects of anakinra in Lewis rats with collagen-induced arthritis.

针对胶原蛋白诱导性关节炎的 Lewis 大鼠，采用群体药代动力学-药效学-疾病进展模型研究阿那白滞素的作用

期刊:Journal of Pharmacokinetics and Pharmacodynamics
影响因子:2.8
doi:10.1007/s10928-011-9219-z
Liu Dongyang, Lon Hoi-Kei, Dubois Debra C, Almon Richard R, Jusko William J
炎症/感染
关节炎
Rat
炎症
发表日期：2011
文献求助 收藏